Los 10 principales competidores de kin.es

colgate.com

You can make a big difference every time you brush by changing a few small actions as Saving the water, recyclable your tube and buy sustainable product as the colgate ones.

oralb.pt

Saiba mais sobre sintomas, causas, tratamentos e prevenção de problemas de saúde oral em OralB.pt

dentaid.es

Pagina principal de DENTAID®

curaprox.fr

Se brosser les dents avec Curaprox est doux, agréable et sain... même lorsqu'on se les blanchit. En savoir plus...

dentego.fr

Centre dentaire Ermont Stalingrad 📍 52-56 Rue de Stalingrad ☎️ 01 85 76 52 04 📧cdsermont@gmail.com ✅ RDV en ligne 🌐

vitaldent.com

Clínicas Dentales Vitaldent: los mejores tratamientos dentales los encontrarás en nuestras clínicas

pierrefabre-oralcare.com

Privacybeleid

chlorhexamed.de

Mundgesundheit beginnt bei der richtigen Ernährung. Denn Lebensmittel können die Mundgesundheit negativ oder positiv beeinflussen. Wichtig ist es vor allem, viel zu trinken sowie zuckerhaltige und säurehaltige Lebensmittel möglichst zu vermeiden.

bactidol.com.ph

Itchy or Dry Cough can be caused by the inflammation of your throat and upper airways, which results in a tickling sensation. This type of cough comes with little to no phlegm or mucus. Sometimes, you also develop sore throat due to frequent coughing.

icpahealth.com

Introduction Oral Lichen Planus (OLP) presents a chronic management challenge for the dental professional. While topical and systemic corticosteroids remain the traditional first-line therapy, their long-term use is frequently limited by contraindications, patient intolerance, or the risk of secondary candidiasis. A recent randomized control study involving thirty patients with recalcitrant OLP offers a significant clinical insight: systemic non-steroidal agents like Dapsone can achieve therapeutic parity with Prednisolone. However, the study also highlights a critical component of successful OLP management that often sits in the shadow of systemic drugs—comprehensive topical symptom control. The Study: Comparison of Efficacy The research compared Group I (Prednisolone 10 mg BID) against Group II (Dapsone 100 mg daily). Both groups showed substantial remission: Reduction in Lesion Size: 65% for the steroid group vs. 62% for the nonsteroid group. Reduction in Pain Intensity: 88% for the steroid group vs. 91% for the nonsteroid group. The conclusion is clear: Dapsone is a viable alternative when steroids are contraindicated. But perhaps the most actionable takeaway for the daily practitioner is the standardized supportive protocol used for all participants. The Role of Benzydamine and Benzocaine in OLP Therapy In this study, regardless of the systemic medication assigned, every patient was prescribed a… Read More